AKTX
Akari Therapeutics

8,662
Loading...
Loading...
News
all
press releases
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HRT, NX, AKTX
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HRT, NX, AKTX SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HRT, NX, AKTX PR Newswire NEW YORK, May 24, 2024 NEW YORK, May 24, 2024...
PR Newswire·1y ago
News Placeholder
More News
News Placeholder
Akari Therapeutics Non-GAAP EPS of $0.00
Akari Therapeutics Non-GAAP EPS of $0.00...
SeekingAlpha.com: All News·1y ago
News Placeholder
Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights
BOSTON and LONDON, April 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory...
Globe Newswire·1y ago
News Placeholder
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates VIVK, MINM, SDPI, AKTX
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates VIVK, MINM, SDPI, AKTX SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates VIVK, MINM, SDPI, AKTX PR Newswire NEW YORK, March 18, 2024 NEW YORK, March...
PR Newswire·1y ago
News Placeholder
SHAREHOLDER ALERT: The M&A Class Action Launches Investigation of the Merger SDPI, MINM, SCX, AKTX
NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of Monteverde & Associates PC (the M&A Class Action Firm ), has recovered money for shareholders and is...
Globe Newswire·1y ago
News Placeholder
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates VIVK, MINM, SDPI, AKTX
NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
Globe Newswire·1y ago
News Placeholder
Kuehn Law Encourages VIVK, MINM, SDPI, and AKTX Investors to Contact Law Firm
Kuehn Law Encourages VIVK, MINM, SDPI, and AKTX Investors to Contact Law Firm Kuehn Law Encourages VIVK, MINM, SDPI, and AKTX Investors to Contact Law Firm PR Newswire NEW YORK, March 15, 2024 NEW...
PR Newswire·1y ago
News Placeholder
Akari Therapeutics (NASDAQ:AKTX) Research Coverage Started at StockNews.com
Equities research analysts at StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX Get Free Report) in a research report issued to clients and investors on Friday. The...
Zolmax·1y ago
News Placeholder
INVESTIGATION UPDATE: Halper Sadeh LLC Investigates IGT, AKTX, SDPI, VIVK
NEW YORK, March 09, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
Globe Newswire·2y ago
News Placeholder
Akari Therapeutics (NASDAQ:AKTX) Now Covered by StockNews.com
Equities researchers at StockNews.com began coverage on shares of Akari Therapeutics (NASDAQ:AKTX Get Free Report) in a research note issued to investors on Thursday. The brokerage set a...
Zolmax·2y ago

Latest AKTX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.